Study Summary
A Study of Metabolically Armed CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell Acute Lymphoblastic Leukemia
Want to learn more about this trial?
Request More InfoInterventions
Metabolically Armed CD19 CAR-T cellsDRUG
Each subject receive metabolically armed CD19 CAR-T cells by intravenous infusion.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Anhui Provincial Hospital | Hefei | Anhui | China |